Inst Diagnosti (INDISA) - Net Assets

Latest as of June 2025: CL$114.04 Billion CLP ≈ $127.53 Million USD

Based on the latest financial reports, Inst Diagnosti (INDISA) has net assets worth CL$114.04 Billion CLP (≈ $127.53 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CL$305.25 Billion ≈ $341.38 Million USD) and total liabilities (CL$191.22 Billion ≈ $213.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Inst Diagnosti to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CL$114.04 Billion
% of Total Assets	37.36%
Annual Growth Rate	13.77%
5-Year Change	117.8%
10-Year Change	228.72%
Growth Volatility	23.74

Inst Diagnosti - Net Assets Trend (2014–2025)

This chart illustrates how Inst Diagnosti's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Inst Diagnosti to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Inst Diagnosti (2014–2025)

The table below shows the annual net assets of Inst Diagnosti from 2014 to 2025. For live valuation and market cap data, see INDISA stock market capitalisation.

Year	Net Assets	Change
2025-12-31	CL$207.27 Billion ≈ $231.80 Million	+89.88%
2024-12-31	CL$109.16 Billion ≈ $122.07 Million	+4.94%
2023-12-31	CL$104.02 Billion ≈ $116.33 Million	+2.28%
2022-12-31	CL$101.70 Billion ≈ $113.74 Million	+6.87%
2021-12-31	CL$95.17 Billion ≈ $106.43 Million	+12.19%
2020-12-31	CL$84.82 Billion ≈ $94.86 Million	+3.55%
2019-12-31	CL$81.92 Billion ≈ $91.61 Million	+7.67%
2018-12-31	CL$76.08 Billion ≈ $85.09 Million	+10.27%
2017-12-31	CL$69.00 Billion ≈ $77.16 Million	+9.43%
2016-12-31	CL$63.05 Billion ≈ $70.51 Million	+11.15%
2015-12-31	CL$56.73 Billion ≈ $63.44 Million	+13.09%
2014-12-31	CL$50.16 Billion ≈ $56.10 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Inst Diagnosti's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 66.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CL$57.07 Billion	27.53%
Other Components	CL$150.20 Billion	72.47%
Total Equity	CL$207.27 Billion	100.00%

Inst Diagnosti Competitors by Market Cap

The table below lists competitors of Inst Diagnosti ranked by their market capitalization.

Company	Market Cap
Hunan Kylinsec Technology Co. Ltd. A SHG:688152	$459.70 Million
Digi Communications NV RO:DIGI	$459.75 Million
The Metals Royalty Company Inc. Common Stock NASDAQ:TMCR	$459.76 Million
DINGDONG CAYMAN 2ADR/3 A F:945	$459.79 Million
Jiangyin Pivot Automotive Products Co. Ltd. SHE:301181	$459.54 Million
ProCredit Holding AG & Co KGaA XETRA:PCZ	$459.41 Million
Laxmi Organic Industries Limited NSE:LXCHEM	$459.31 Million
Krishana Phoschem Limited NSE:KRISHANA	$459.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inst Diagnosti's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 109,156,351,000 to 207,269,586,000, a change of 98,113,235,000 (89.9%).
Net income of 15,659,985,000 contributed positively to equity growth.
Dividend payments of 2,184,419,000 reduced retained earnings.
New share issuances of 20,046,719,000 increased equity.
Other factors increased equity by 64,590,950,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CL$15.66 Billion	+7.56%
Dividends Paid	CL$2.18 Billion	-1.05%
Share Issuances	CL$20.05 Billion	+9.67%
Other Changes	CL$64.59 Billion	+31.16%
Total Change	CL$-	89.88%

Book Value vs Market Value Analysis

This analysis compares Inst Diagnosti's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.98x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 5.47x to 1.98x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CL$489.58	CL$2678.60	x
2018-12-31	CL$539.87	CL$2678.60	x
2019-12-31	CL$581.26	CL$2678.60	x
2020-12-31	CL$601.89	CL$2678.60	x
2021-12-31	CL$675.27	CL$2678.60	x
2022-12-31	CL$701.65	CL$2678.60	x
2023-12-31	CL$738.09	CL$2678.60	x
2024-12-31	CL$753.09	CL$2678.60	x
2025-12-31	CL$1350.90	CL$2678.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inst Diagnosti utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.56%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.75%
• Asset Turnover: 0.67x
• Equity Multiplier: 1.97x
Recent ROE (7.56%) is below the historical average (14.24%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	23.40%	11.32%	0.93x	2.23x	CL$6.72 Billion
2015	23.15%	11.23%	0.86x	2.39x	CL$7.46 Billion
2016	20.51%	10.08%	0.83x	2.45x	CL$6.63 Billion
2017	17.23%	8.59%	0.87x	2.32x	CL$4.99 Billion
2018	19.31%	10.11%	0.89x	2.15x	CL$7.09 Billion
2019	14.20%	7.74%	0.89x	2.06x	CL$3.44 Billion
2020	4.13%	2.51%	0.76x	2.15x	CL$-4.98 Billion
2021	21.70%	10.95%	0.82x	2.43x	CL$11.13 Billion
2022	12.83%	6.82%	0.70x	2.68x	CL$2.88 Billion
2023	0.14%	0.07%	0.79x	2.66x	CL$-10.26 Billion
2024	6.67%	3.04%	0.88x	2.50x	CL$-3.64 Billion
2025	7.56%	5.75%	0.67x	1.97x	CL$-5.07 Billion

Industry Comparison

This section compares Inst Diagnosti's net assets metrics with peer companies in the Medical Care Facilities industry.

No peer company data available for comparison.

About Inst Diagnosti

SN:INDISA Chile Medical Care Facilities

Market Cap

$459.61 Million

CL$410.98 Billion CLP

Market Cap Rank

#12869 Global

#55 in Chile

Share Price

CL$2678.60

Change (1 day)

-0.76%

52-Week Range

CL$2106.10 - CL$2889.90

All Time High

CL$2889.90